Malaysian biotech CytoMed Therapeutics files for $10M US IPO
Malaysian biotech CytoMed Therapeutics (GDTC) has filed for a proposed $15M initial public offering. CytoMed is a biotech company spun off from Agency for Science, Technology and Research (A*STAR), Singapore’s lead R&D agency in public sector and focus on translating … Continue reading Malaysian biotech CytoMed Therapeutics files for $10M US IPO